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Alonso Pardo-Vargas1, Martina Delbianco1 and
Peter H Seeberger1,2Access to complex carbohydrates remains a limiting factor for
the development of the glycosciences. Automated glycan
assembly (AGA) has accelerated and simplified the synthetic
process and, with the first commercially available instrument
and building blocks, glycan synthesis can now be practiced by
any chemist. All classes of glycans, including sulfated or
sialylated carbohydrates and polysaccharides as long as
50mers are now accessible owing to optimized reaction
conditions and new methodologies. These synthetic glycans
have helped to understand many biological functions and to
advance diagnostic and vaccine development. Establishing
detailed structure–function relationships will eventually enable
the production of unnatural materials with tuned properties.Addresses
1Department of Biomolecular Systems, Max Planck Institute of Colloids
and Interfaces, Am Mu¨hlenberg 1, 14476 Potsdam, Germany
2 Freie Universita¨t Berlin, Institute of Chemistry and Biochemistry,
Arnimallee 22, 14195 Berlin, Germany
Corresponding author: Seeberger, Peter H (peter.seeberger@mpikg.
mpg.de)
Current Opinion in Chemical Biology 2018, 46:48–55
This review comes from a themed issue on Synthetic biomolecules
Edited by Richard J. Payne and Nicolas Winssinger
For a complete overview see the Issue and the Editorial
Available online 30th April 2018
https://doi.org/10.1016/j.cbpa.2018.04.007
1367-5931/ã 2018 The Authors. Published by Elsevier Ltd. This is an
open access article under the CC BY-NC-ND license (http://creative-
commons.org/licenses/by-nc-nd/4.0/.
Introduction
Carbohydrates are the most abundant biopolymers on
earth [1], and their complexity is evident in the variety
of important roles they play, which include structural
definition, energy storage, and regulation of host–patho-
gen interactions. Nevertheless many of these biological
functions remain largely descriptive or unknown. In
contrast, other biopolymers such as oligonucleotides
(DNA and RNA) and proteins are well understood at
the molecular level. For these biopolymers, automated
sequencing and synthesis fuel rapid progress in the
development of molecular biology tools. The easy manip-
ulation of polynucleotides in concert with gene expres-
sion technologies, made pure proteins accessible, thereby
advancing proteomics and genomics [2].Current Opinion in Chemical Biology 2018, 46:48–55Molecular glycobiology is still in its infancy. Access to
structurally diverse and complex carbohydrate structures
is either achieved by extraction from natural sources or by
chemical synthesis. Several monosaccharides serve as
building blocks, forming branched structures, with each
glycosidic linkage creating a new stereogenic center.
Glycan diversity renders purification from natural sources
very challenging and not always possible. Chemical syn-
thesis is frequently the only way to obtain pure glycans.
The total synthesis of glycans is based on the stereose-
lective installation of glycosidic linkages and protecting
group manipulations [3–5]. These protocols have
improved to the point where complex structures, such
as a 92 unit arabinogalactan, can be prepared on a milli-
gram scale [6]. Total synthesis is labor intensive, and
often requires months or even years to complete [7]. For
the development of molecular glycobiology and material
science, pure natural and non-natural structures are
required before structure–function relationships can be
established. The development of reliable automated
glycan assembly (AGA) technologies summarized here
forms the basis for a better understanding of glycans and
for the development of molecular glycobiology.
Solution-phase methods
Most solution-based methods, aiming to accelerate the
synthetic process by reducing the number of purification
steps in between, are not yet fully automated and still
remain labor intensive. The semi-automated computer-
based one-pot synthesis is based on the sequential addi-
tion of building blocks (BBs) according to the difference
in their reactivity calculated by the OptiMer software [8].
This conceptually attractive methodology requires many
different monosaccharide, disaccharide and trisaccharide
BBs. Another one-pot method is based on the anodic
oxidation of the glycosyl donor in the presence of tetra-
butylammonium triflate (Bu4NOTf) in an electrolysis cell
to generate the corresponding triflate donor. The thiogly-
coside acceptor is then added and, upon glycosylation, the
oxidation process is repeated [9]. An instrument was
developed to control temperature, delivery of reagents,
and the electrical potential of the reaction cell. DFT
calculations are performed prior synthesis to estimate the
oxidation potentials of the building blocks. Recently, the
synthesis of the GPI anchor core trisaccharide [10] and a
TMG-chitotriomycin precursor [11] were reported.
Another method to simplify purification uses a fluorous
tag linker that is coupled to the desired glycan. After
every step, deprotection and chain elongation, the taggedwww.sciencedirect.com
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fluorous solid-phase extraction (FSPE). A robot can han-
dle the solutions autonomously [12]. Linear and branched
b-oligomannosides were synthesized using a b-directing
C5 participation strategy [13,14]. Recently, automated
fluorous-assisted synthesis using hypervalent iodonium
as glycosylation promoter at ambient temperatures per-
mitted the synthesis of a b(1,6)-glucan tetramer [15]. A
renewable benzyl-type fluorous tag was prepared to
reduce costs [16]. To date, FSPE techniques was mainly
applied to the synthesis of relatively short oligomers
rather than long polysaccharides. Similar to fluorous tag
methodology, the hydrophobically assisted switching
phase method (HASP) uses a hydrophobic tag to simplify
the separation of the desired oligosaccharide from the
reaction mixture. This strategy was illustrated in the
context of a nonamannoside synthesis [17].
Solid-phase methods
Solid-phase oligosaccharide synthesis has been fully auto-
mated. The Glyconeer 2.1TM was the result of a devel-
opment process starting from an adapted peptide synthe-
sizer via multiple home-built systems [18,19,20]
(Figure 1a and 1b). With this Glyconeer 2.1TM, the
desired oligosaccharide is assembled using repeating
cycles of glycosylation, capping and deprotection steps
on a polystyrene Merrifield resin (Figure 1c). Excess
reagents are removed by simple filtration.
Linker
The glycan is attached to the solid support via a linker
that is cleaved upon completion of the assembly, afford-
ing the target compound. The linker has to tolerate the
reaction conditions during the assembly process and
permit the easy liberation of the final product. Following
metathesis labile linkers [21,22] and several base-labile
linkers [23–25], the photocleaveble linkers were devel-
oped for their orthogonality to a wide range of reaction
conditions (Figure 1d). Photocleavable linkers are stable
in both acidic and basic conditions and compatible with
wide variety of protecting groups including Nap, Fmoc,
Lev, Bn and Bz. Linker 3 affords conjugation-ready
glycans [26]. Traceless linker 4 affords a free reducing
end after the final deprotection [27]. The current chal-
lenge involves further development of the photocleavage
efficiency, currently around 60–70%, to improve overall
yields for AGA.
AGA coupling cycle
The glycosylation reaction is the key step during AGA. A
set of ‘approved’ building blocks was developed and
many BBs are now commercially available [20]. For each
‘approved’ BB, key reaction parameters, such as activator,
reaction temperature, and equivalents of BB per cycle
were optimized and reported. In order to minimize the
formation of deletion sequences, a large excess of sugar
donor (ten equiv. per coupling step over two glycosylationwww.sciencedirect.comcycles) was traditionally used to drive the reaction to
completion [20]. Optimized reaction temperature and
concentration permit the completion of the reaction with
only one glycosylation cycle (five to eight equiv. of BB)
[28].
To further improve the coupling cycle, a capping step was
introduced to block any unreacted acceptor in less than
30 min by acetylation using methanesulfonic acid and
acetic anhydride [29]. Capping is compatible with all
the protecting groups used to date, increases the isolated
yield of the desired compound and facilitates the purifi-
cation of the reaction mixture by reducing the amount of
side-products. The capping step was tested for the assem-
bly of a polymannoside (50mer) resulting in a four-fold
yield increase (20% yield) while reducing the amount of
building block used by 33% [29]. Capping is now
incorporated in the standard coupling cycle.
Synthetic improvements
AGA had been mainly used to synthesize trans-glycosidic
linkages, where the C2-participating protecting group
ensures stereoselective couplings. Since stereocontrol
during cis-glycosylations cannot rely on C2-participation,
anomeric mixtures are normally observed. The use of a
particular mannuronic acid donor, together with activa-
tion at low temperature, has permitted the challenging
synthesis of mannuronic acid alginate oligomers, with up
to twelve cis-linkages [30]. More recently, oligosacchar-
ides containing multiple cis-glycosidic linkages were pre-
pared efficiently by AGA using monosaccharide BBs
equipped with acetyl or benzoyl esters as remote partici-
pating protecting groups [31] (Figure 2). Nine biologi-
cally important structures containing cis-galactosidic and
cis-glucosidic linkages were assembled.
Access to sialylated glycans remains challenging. In par-
ticular, glycosylation with N-acetyl-neuraminic acid
(Neu5Ac) results in low yields and anomeric mixtures
due to low reactivity and lack of stereo control. The
attempt to produce a(26) and a(23) sialylated glycans
by AGA using sialyl-monomer was successful, albeit low
yielding [32]. A combination where the glycan backbone
is obtained by AGA and further functionalized with
sialyltransferase (PmST1) permitted easy access to five
(2,3)-sialylated glycans [33] (Figure 2).
Glycosaminoglycans (GAGs) are an important class of
negatively charged glycans and one of the most challeng-
ing targets for carbohydrate chemists. The first successful
AGA of hyaluronic acid (HA) oligomers was reported
using a disaccharide BB [34]. In addition, most GAGs
structures are highly sulfated, posing additional chal-
lenges to the synthesis of such compounds. Chondroitin
sulfate GAGs with different sulfation patterns were pre-
pared using a glucuronic acid BB and two N-acetyl-
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(a) The commercial Glyconeer 2.1TM AGA synthesizer, (b) home-built AGA synthesizer, (c) overview of the coupling cycle, (d) examples of the
different linkers used for AGA.protecting groups. The Fmoc group was used for chain
elongation and the orthogonal levulinoyl (Lev) esters
marked the hydroxyl groups for sulfation. Fully protected
chondroitin-6-sulfate and chondroitin-4-sulfate hexasac-
charides were synthesized [26,35]. Keratan sulfates (KS)
containing b(1-4) galactose, b(1-3) N-acetyl-galactos-
amine and different sulfation patterns were obtained
following a similar approach. Three different temporary
protecting groups were exploited: Nap and Lev esters for
subsequent sulfation and Fmoc for chain elongation. The
orthogonality of the protecting groups permitted the
synthesis of four differently sulfated KS tetrasaccharides
from a common tetrasaccharide precursor [36] (Figure 2).
Most of the previously described advancements were
applied to the synthesis of oligosaccharides associated
with blood group determinants [37]. Those are tumor-
associated carbohydrate antigens (TACAs) and cancer
vaccine candidates, also associated with immunodefi-
ciency disorders, atherosclerosis, and Guillain–Barre´ syn-
drome. cis-Linkage formation, sulfation as well as the use
of orthogonal temporary protective groups permitted theCurrent Opinion in Chemical Biology 2018, 46:48–55fast assembly of biologically relevant glycans including
H-type I (3) and II (4) glycans.
Instrumentation
Fifteen years since the first home-built synthesizer,
finally, the commercial Glyconeer 2.1TM has been placed
in several laboratories [19]. The combination of this
instrument with standardized purifications and quality-
control techniques for the easy access to synthetic glycans
has fueled the development of glycoscience [19,38,39].
The introduction of a novel cyanopivaloyl (Piv-CN)
directing/protecting group into a rhamnose BB was key
to the assembly of 16mer oligorhamnans on the Glyco-
neer 2.1TM [40].
Efforts to develop an inexpensive synthesis instrument
employed a modified HPLC [41,42]. A column packed
with the solid support is used as a reactor. A JandaJel resin
functionalized with a base labile linker serves as the
glycosyl acceptor. HPLC pumps are used to deliver
the glycosyl donor (glucosyl imidate BB, five-ten equiva-
lents) and the deprotection solution. The promotor iswww.sciencedirect.com
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Recent AGA milestones.delivered through the autosampler. The synthesis is
monitored using the integrated UV detector set at
254 nm. This simple set up has been limited to the
production of a pentaglucoside so far. Temperature con-
trol throughout the synthesis and delivery lines for
reagents will be key points to be address for further
development of this system.
Applications of glycans assembled by AGA
Glycan arrays
Glycan arrays are standard tools for the high throughput
analysis of protein-carbohydrate interactions [43,44].
Antibodies, associated with diseases, can be detected
in biological samples on glycan microarrays [43,45].
Access to pure glycans for covalent attachment to a
surface of the array remains as limiting factor. AGA is
the ideal tool for the creation of large collections of related
compounds, permitting the study of glycans through a
medicinal chemistry approach (Figure 3). Conjugation-
ready linear b(1,3)-glucan and branched b(1,3)b(1,6)-glu-
can oligosaccharides were assembled and immobilized on
microarrays. Incubation with human sera revealed that
most individuals create antibodies that bind to protective
linear glucan, but not to the non-protective branched
analogues [46]. Synthetic keratan sulfate analogues with
different sulfation patterns obtained with AGA were
printed on microarrays. Specific interaction betweenwww.sciencedirect.comthe disulfated KS tetrasaccharide and the adeno-associ-
ated virus AAVrh10 gene-therapy vector were observed
[36].
AGA was used to create glycans for determining the
binding epitopes of a large number of plant cell-wall
glycan-directed mAbs using a microarray [47–49]. This
information provided a tool for in situ cell wall labeling
studies to gain detailed information on cell wall poly-
saccharides in the model organism Brachypodium distach-
yon [50]. The binding specificities for 25 mAbs that rec-
ognize galactosylated XG structures were determined
using the same approach [51].
Enzyme substrate determination
The oligosaccharide fragments of plant glycans assem-
bled by AGA were used to characterize the enzymes
involved in biosynthesis (Figure 3). Plant arabinogalac-
tan, glucan and arabinoxylan oligosaccharides were
assembled to study the substrate specificity of b(1,4)-
endogalactanases [52], lichenase [53], and to map the
active site of GH10 and GH11 xylanase [54]. These
findings have implications for the structural analyses of
pectic polysaccharides. This plants oligosaccharide tool-
box is currently applied to the characterization of biosyn-
thetic enzymes and arabinogalactan-directed and arabi-
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Applications of glycans synthesized using AGA.Vaccine development
Glycoconjugates containing synthetic oligosaccharides
attached to a carrier protein are attractive candidates
as semisynthetic vaccines against infectious diseases
(Figure 3). Semisynthetic oligosaccharides, resembling
the capsular polysaccharides from Streptococcus Pneumonia
ST8, assembled with AGA, were combined with the
marketed polysaccharide-based pneumococcal vaccine
Prevnar 131 while retaining the immunogenicity of both
components [56]. Synthetic antigens from ST3, prepared
by AGA, are tested as vaccine candidates [57].
Materials chemistry
The synthesis of 50mer oligomannosides (Figure 2), the
longest polysaccharides assembled from monomers, set
the stage to use AGA for the investigations of carbohy-
drates as materials [29,58]. In the attempt to expand the
use of AGA to the synthesis of different polysaccharides,
well-defined oligosaccharides and polysaccharides,
resembling natural as well as unnatural structures, wereCurrent Opinion in Chemical Biology 2018, 46:48–55prepared. Those are ideal probes for the fundamental
study of glycans [28]. Molecular dynamics simulations
and NMR analysis suggested that different classes of
polysaccharides adopt fundamentally different conforma-
tions. Single-site substitutions alter such conformations,
granting the ability to tune the shape and properties (i.e.
solubility) of such compounds (Figure 3).
Perspectives
Over the past two decades AGA has evolved from humble
beginnings to a reliable synthesizer, with optimized reac-
tion conditions, and commercially available building
blocks that have made the rapid synthesis of complex
oligosaccharides a reality [19,20]. Several orthogonal
protecting groups are routinely used, permitting the fast
formation of linear, as well as branched, structures. Even
though challenging cis-linkages and structures such as
charged polysaccharides are now accessible, some lin-
kages (e.g. b-mannose) as well as the stability of sulfates
during the deprotection process remain synthetic hurdles.www.sciencedirect.com
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fated structures) remained confined to short oligomers,
with only few examples extending past hexamers. The
next important step will be the implementation of such
methodologies to access long polysaccharides, expanding
the complexity of synthetic glycans. Additionally, as
longer polysaccharides can be assembled, new challenges
arise, such as the formation of insoluble compounds and/
or aggregates after global deprotection [28]. The
detailed structural analysis of defined oligosaccharides
and polysaccharides will advance the synthesis. Specific
substitution aiming to alter the structure and properties of
these compounds will be systematically studied using
AGA. These achievements, together with improvements
in quality control and purifications techniques, will have
an enormous impact in glycoscience [38].
With an expanding collection of pure and well-defined
glycans it will be possible to shed light on new aspects of
glycobiology such as carbohydrate–protein interactions as
well as to aid the development and characterization of
new enzymes and antibodies. The development of new
diagnostics and vaccines is being enabled by AGA. Mul-
tivalent systems, so far limited to simple monosaccharides
or disaccharides [59], can now benefit from AGA to
encompass more complex structures to better resemble
the biological environment. AGA will grant access to new
carbohydrate-based materials dissecting fundamental
interactions in polysaccharides. In the future, we envision
the development of unnatural compounds with tuned
properties. With the availability of AGA technology to
synthesize glycans, analogous to that for DNA and pep-
tides, we expect the opening up of new possibilities and
applications for carbohydrates.
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